Pharma Stocks
-
Here’s Why The Fund Sold Regeneron Pharmaceuticals (REGN)
American Century Investments, an investment management company, released its first-quarter 2026 investor letter for the “American Century Investments Focused Dynamic…
Read More » -
Vertex Pharma stock heads into the open after a 3.1 percent drop
Vertex Pharma, US92532F1003 Published on 09/09/2026 at 06:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief…
Read More » -
Stocks to watch: Sun Pharma, Suzlon Energy, OMCs, Biocon, IHCL, Tata Power | Markets News
Stocks to watch today: GIFT Nifty is indicating yet another weak session on Wednesday as rising crude oil prices and…
Read More » -
Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Johnson & Johnson (JNJ) closed the most recent trading day at $269.12, moving -2.22% from the previous trading session. This…
Read More » -
Bristol Myers Squibb (BMY) Posts Positive Phase 2 Arlo Cel Results In Myeloma
Bristol Myers Squibb (NYSE:BMY) reported positive Phase 2 QUINTESSENTIAL trial data for arlocabtagene autoleucel, a GPRC5D-targeted CAR T cell therapy…
Read More » -
How Investors May Respond To Royalty Pharma (RPRX) Pelacarsen Trial Failure
Royalty Pharma reported that Novartis’ Phase 3 HORIZON trial for pelacarsen in atherosclerotic cardiovascular disease did not meet its primary…
Read More » -
What Does Little Green Pharma (ASX:LGP) Bring to the Cannabis Stocks Sector?
Highlights Little Green Pharma’s latest market material places regulated cannabis activity at the centre of attention. The update adds context…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 36, 2026)
Zealand Pharma Company announcement No. 46 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 36, 2026)…
Read More » -
Is Hikma Pharmaceuticals Stock Set To Extend Its Post-Results Rally?
Highlights First-half revenue and profit measures advanced on the prior year across the generics and branded portfolio Management reiterated full-year…
Read More » -
Why Is Little Green Pharma (ASX:LGP) Scaling European Reach?
Highlights Little Green Pharma is in focus after its latest market disclosure clarified current operating priorities. The news is relevant…
Read More »